Lucie Brendel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Lucie Brendel has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Clémentine Leger
UMR 7200 LIT CNRS/Unistra
1 shared publication - Dominique Bonnet
Laboratoire d’Innovation Thérapeutique, UMR 7200, Centre National de la Recherche Scientifique, Université de Strasbourg, Illkirch, France
1 shared publication - Halina Anton
Laboratory of Bioimaging and Pathologies (LBP), UMR 7021, CNRS, Université de Strasbourg, 74 Route du Rhin, Illkirch-Graffenstaden 67401, France
1 shared publication - Line Bourel-Bonnet
Chemobiology and Pharmacognosy for Health (CPS) Team, Strasbourg Institute for Drug Discovery and Development (ITI IMS), Laboratory of Therapeutic Innovation (LIT), UMR 7200 CNRS/Unistra, Faculty of Pharmacy, 74, route du Rhin, Illkirch, 67400, France; University of Strasbourg Institute for Advanced Studies (USIAS), 67000, Strasbourg, France
1 shared publication - Marcela Sabou
Tropical Strasbourg Institute of Parasitology and tropical Pathology, Strasbourg University Hospital
1 shared publication - Mylène Lang
UMR 7200 LIT CNRS/Unistra
1 shared publication
Latest Publications
- Open Access
- 13 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
A Straightforward and Versatile Synthetic Route to Tunable Cyclic Lipopeptides for Fluorescent Echinocandin Analogues
Echinocandins (ECs) are semisynthetic lipocyclohexapeptides introduced in the 2000s to treat invasive fungal infections. They selectively and safely inhibit fungal β-(1,3)-D-glucan synthase, a key enzyme for fungal cell wall integrity, but their precise mechanism remains unclear. Their widespread use has led to emerging resistances, underscoring the need for molecular probes to investigate their action and resistance mechanisms. Due to their structural complexity, only few total syntheses and very limited fluorescent analogues have been reported. Here, we present a solid-phase peptide synthesis (SPPS) strategy to readily access to the EC pharmacophore and to novel fluorescent analogues. Using a safety-catch linker resin, cyclization and cleavage are efficiently combined, affording high-purity cyclic lipopeptides with simplifiedpurification step. Depending on the design, fluorescent tags were introduced either on-resin or in solution via bioconjugation. Several analogues retained antifungal activity against Candida albicans, and their interaction with fungal cells was visualized by confocal microscopy. This versatile methodology delivers some of the first fully synthetic fluorescent echinocandins, providing powerful tools to explore their mechanisms of action and fungal resistance.
- 13 October 2025
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessA Straightforward and Versatile Synthetic Route to Tunable Cyclic Lipopeptides for Fluorescent Echinocandin Analogues
Echinocandins (ECs) are semisynthetic lipocyclohexapeptides introduced in the 2000s to treat invasive fungal infections. They selectively and safely inhibit fungal β-(1,3)-D-glucan synthase, a key enzyme for fungal cell wall integrity, but their precise mechanism remains unclear. Their widespread use has led to emerging resistances, underscoring the need for molecular probes to investigate their action and resistance mechanisms. Due to their structural complexity, only few total syntheses and very limited fluorescent analogues have been reported. Here, we present a solid-phase peptide synthesis (SPPS) strategy to readily access to the EC pharmacophore and to novel fluorescent analogues. Using a safety-catch linker resin, cyclization and cleavage are efficiently combined, affording high-purity cyclic lipopeptides with simplifiedpurification step. Depending on the design, fluorescent tags were introduced either on-resin or in solution via bioconjugation. Several analogues retained antifungal activity against Candida albicans, and their interaction with fungal cells was visualized by confocal microscopy. This versatile methodology delivers some of the first fully synthetic fluorescent echinocandins, providing powerful tools to explore their mechanisms of action and fungal resistance.